Avant Brands Inc. (AVTBF)
OTCMKTS · Delayed Price · Currency is USD
0.6281
-0.0570 (-8.32%)
Sep 30, 2025, 3:52 PM EDT
Avant Brands Market Cap
Avant Brands has a market cap or net worth of $6.83 million as of September 30, 2025. Its market cap has decreased by -43.42% in one year.
Market Cap
6.83M
Enterprise Value
17.02M
Revenue
26.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.63
Market Cap Chart
Since June 22, 2018, Avant Brands's market cap has decreased from 90.04M to 6.83M, a decrease of -92.41%. That is a compound annual growth rate of -29.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2025 | 7.41M | 92.75% |
| Dec 31, 2024 | 3.84M | -86.01% |
| Dec 29, 2023 | 27.47M | 8.87% |
| Dec 30, 2022 | 25.23M | -54.48% |
| Dec 31, 2021 | 55.43M | 378.03% |
| Dec 31, 2020 | 11.60M | -42.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 742.59M |
| Tian'an Technology Group | 718.73M |
| Glass House Brands | 516.60M |
| Northwest Biotherapeutics | 387.17M |
| CytoDyn | 332.57M |
| American Oncology Network | 305.31M |
| Nika Pharmaceuticals | 301.74M |